InvestorsHub Logo
Followers 3
Posts 1318
Boards Moderated 0
Alias Born 06/06/2017

Re: Abundance88 post# 26982

Tuesday, 10/29/2019 1:03:28 PM

Tuesday, October 29, 2019 1:03:28 PM

Post# of 34701
OK, Hill Street will be late to the market, and any revenue from license fees to Lexaria will be delayed. Will Lexaria become a market maker eventually? I hope so, but it's going to be a tough slog against an integrated producer like Canopy. They grow the bud, extract, infuse, bottle and market all in-house and they don't have to pay license fees for their infusion tech. It's going to be hard to compete on costs. Canopy also claims great taste, quick onset-offset, precise dosing and low-calorie products. Are they better? I don't know, I'd have to try each.
I'm also a shareholder (disappointed) in BEER.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LEXX News